These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 104814)

  • 1. Identification of nephritic factor as an immunoglobulin.
    Williams DG; Bartlett A; Duffus P
    Clin Exp Immunol; 1978 Sep; 33(3):425-9. PubMed ID: 104814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C3 nephritic factor (C3NeF): dissociation of cell-bound and fluid phase stabilization of alternative pathway C3 convertase.
    Ng YC; Peters DK
    Clin Exp Immunol; 1986 Aug; 65(2):450-7. PubMed ID: 3641695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of nephritic factor of the alternative complement pathway by Epstein Barr virus-transformed B cell lines derived from a patient with membranoproliferative glomerulonephritis.
    Hiramatsu M; Balow JE; Tsokos GC
    J Immunol; 1986 Jun; 136(12):4451-5. PubMed ID: 3011894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological significance of the C3 nephritic factor in membranoproliferative glomerulonephritis.
    Schena FP; Pertosa G; Stanziale P; Vox E; Pecoraro C; Andreucci VE
    Clin Nephrol; 1982 Nov; 18(5):240-6. PubMed ID: 7151338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further evidence for the antibody nature of C3 nephritic factor (C3NeF).
    Daha MR; van Es LA
    J Immunol; 1979 Aug; 123(2):755-8. PubMed ID: 379217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypocomplementaemia of poststreptococcal acute glomerulonephritis is associated with C3 nephritic factor (C3NeF) IgG autoantibody activity.
    Frémeaux-Bacchi V; Weiss L; Demouchy C; May A; Palomera S; Kazatchkine MD
    Nephrol Dial Transplant; 1994; 9(12):1747-50. PubMed ID: 7708258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C3 nephritic factor and hypocomplementaemia in a clinically healthy individual.
    Gewurz AT; Imherr SM; Strauss S; Gewurz H; Mold C
    Clin Exp Immunol; 1983 Oct; 54(1):253-8. PubMed ID: 6616970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial incidence of C3 nephritic factor, partial lipodystrophy and membranoproliferative glomerulonephritis.
    Power DA; Ng YC; Simpson JG
    Q J Med; 1990 Apr; 75(276):387-98. PubMed ID: 2385743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective disappearance of C3NeF IgG autoantibody in the plasma of a patient with membranoproliferative glomerulonephritis following renal transplantation.
    Frémeaux-Bacchi V; Weiss L; Brun P; Kazatchkine MD
    Nephrol Dial Transplant; 1994; 9(7):811-4. PubMed ID: 7970124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the classical pathway of complement by the C3NeF-stabilized cell-bound amplification convertase.
    Daha MR; van Es LA
    J Immunol; 1979 Mar; 122(3):801-5. PubMed ID: 448075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mechanisms of action and clinical importance of C3-nephritic-factor (author's transl)].
    Lanzer G; Pogglitsch H; Tilz GP
    Acta Med Austriaca; 1981; 8(1):7-13. PubMed ID: 6908995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of C3 nephritic factor by cultured lymphocytes derived from a patient with partial lipodystrophy.
    Yamada A; Ohi H; Okano K; Watanabe S; Seki M; Hatano M; Koitabashi Y
    J Clin Lab Immunol; 1988 Sep; 27(1):35-7. PubMed ID: 3251045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A serum factor in chronic hypocomplementemic hephritis distinct from immunoglobulins and activating the alternate pathway of complement.
    Vallota EH; Götze O; Spiegelberg HL; Forristal J; West CD; Müller-Eberhard HJ
    J Exp Med; 1974 May; 139(5):1249-61. PubMed ID: 4207623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two types of C3 nephritic factor: properdin-dependent C3NeF and properdin-independent C3NeF.
    Tanuma Y; Ohi H; Hatano M
    Clin Immunol Immunopathol; 1990 Aug; 56(2):226-38. PubMed ID: 2143128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C3 nephritic factor and C4 nephritic factor in the serum of two patients with hypocomplementaemic membranoproliferative glomerulonephritis.
    Tanuma Y; Ohi H; Watanabe S; Seki M; Hatano M
    Clin Exp Immunol; 1989 Apr; 76(1):82-5. PubMed ID: 2736802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Progress in the knowledge of complement. II. Nephritic factors].
    Leibowitch J; Lesavre P
    Nouv Presse Med; 1979 Jul; 8(30):2447-8. PubMed ID: 493036
    [No Abstract]   [Full Text] [Related]  

  • 17. Partial lipodystrophy, mesangiocapillary glomerulonephritis, and complement dysregulation. An autoimmune phenomenon.
    Levy Y; George J; Yona E; Shoenfeld Y
    Immunol Res; 1998 Aug; 18(1):55-60. PubMed ID: 9724849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity, polypeptide chain composition and antigenic reactivity of C3 nephritic factor.
    Daha MR; Austen KF; Fearon DT
    J Immunol; 1978 Apr; 120(4):1389-94. PubMed ID: 76663
    [No Abstract]   [Full Text] [Related]  

  • 19. Human polyclonal and monoclonal IgG and IgM complement 3 nephritic factors: evidence for idiotypic commonality.
    Tsokos GC; Stitzel AE; Patel AD; Hiramatsu M; Balow JE; Spitzer RE
    Clin Immunol Immunopathol; 1989 Oct; 53(1):113-22. PubMed ID: 2475285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of IgG and IgM autoantibody to the alternative pathway C3 convertase in normal individuals and patients with membranoproliferative glomerulonephritis.
    Spitzer RE; Stitzel AE; Tsokos GC
    Clin Immunol Immunopathol; 1990 Oct; 57(1):10-8. PubMed ID: 1697516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.